Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Biosimilars Staff Faces More Transition As Sue Lim Departs After Christl

Feb 25 2019

• By Michael Cipriano

FDASignBldg21Entrance_1200x675

Related Content

Celltrion’s Rituximab Biosimilar Has Easy US FDA Panel Ride Despite Questions About Narrow Label

Oct 10 2018

Roche’s Gazyva Clears FDA, But First Breakthrough Approval Breaks No Speed Barriers

Nov 01 2013

FDA Biosimilars Chief Leah Christl Joining Amgen; Agency Veteran Sarah Yim Takes Her Place

Feb 03 2019

Early Beleodaq win for Spectrum bodes well for Onxeo

Jul 04 2014

Related Companies

Celltrion, Inc.

Amgen, Inc.

Johnson & Johnson

Genentech, Inc.

Spectrum Pharmaceuticals, Inc.

Additional Topics

United States Biosimilars Biologics Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.